Patent
Antagonists of ligands and uses thereof
| العنوان: | Antagonists of ligands and uses thereof |
|---|---|
| Patent Number: | 8,658,135 |
| تاريخ النشر: | February 25, 2014 |
| Appl. No: | 13/063753 |
| Application Filed: | September 17, 2009 |
| مستخلص: | The invention provides hetero-multivalent ligand binging agents (traps) for members of the TGF-β superfamily, as well as methods for making and using such constructs. In an embodiment of the invention there is provided a hetero-multivalent binding agent with affinity for a member of the TGF-β superfamily. The agent comprises the general structure I: ( |
| Inventors: | O'Connor-McCourt, Maureen D. (Beaconsfield, CA); Sulea, Traian (Kirkland, CA); Zwaagstra, John C. (Chomedey-Laval, CA); Baardsnes, Jason (Montreal, CA); Collins, Catherine (Dorval, CA) |
| Assignees: | National Research Council of Canada (Ottawa, Ontario, CA) |
| Claim: | 1. A hetero-multivalent binding agent with affinity for one or more than one member of the TGF-β superfamily, said agent comprising the general Structure I: ( |
| Claim: | 2. The agent of claim 1 wherein the member of the TGF-β superfamily to which the binding domains have affinity is selected from the group consisting of: TGF-β1, TGF-β2, TGF-β3, activin βA, activin βB, activin βC, activin βE, bone morphogenic protein (BMP) 2, BMP 3, BMP4, BMP 5, BMP 6, BMP 7, BMP 8, BMP 9, BMP 10, BMP 11, BMP 12, BMP 13, BMP 14, BMP 15, growth differentiation factor (GDF) 1, GDF 3, GDF 8, GDF 9, GDF 15, Nodal, Inhibin α, anti-Mullerian Hormone, Lefty 1, Lefty 2, arteman, Persephin and Neurturin. |
| Claim: | 3. The agent of claim 2 wherein the member of the TGF-β superfamily to which the binding domains have affinity is selected from the group consisting of: TGF-β1, TGF-β2, TGF-β3, BMP2, GDF 8, and activin. |
| Claim: | 4. The agent of claim 1 wherein bd4 is the same as bd1, bd2 is the same as bd3, h>0, and d, f, m, and n=1. |
| Claim: | 5. The agent of claim 1 , comprising SEQ ID No 44. |
| Claim: | 6. The agent of claim 1 comprising one or more of SEQ ID NO 1-11, 18-33, 35-43, 65-75, or 82-107, or PTTVTDNNGAVKFP (residues 88-101 of SEQ ID NO:44) as a linker sequence. |
| Claim: | 7. The agent of claim 1 , wherein one or more of bd2, bd3, and bd4 is selected from one of SEQ ID NO 13-17. |
| Claim: | 8. The agent of claim 1 having the general structure V: [chemical expression included] wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 , may be present or not, and when present, may independently be one or more of a protein for targeting, a single domain antibody, a radiotherapy agent, an imaging agent, a fluorescent dye, a fluorescent protein tag, a cytotoxic agent for chemotherapy, a nanoparticle-based carrier, a polymer conjugated to a drug, nanocarrier or imaging agent, a stabilizing agent, a drug, a nanocarrier, a support, and a dendrimer. |
| Claim: | 9. A method of modulating the response of a cell to a TGF-β superfamily member in its environment, said method comprising exposing the cell to an agent of claim 1 . |
| Claim: | 10. A method of purifying or concentrating ligand comprising using the agent of claim 1 immobilized on a solid support to purify or concentrate a ligand from a sample. |
| Claim: | 11. A method of diagnosing a condition characterized in whole or part by an abnormality in levels of one or more TGF-β superfamily members in a subject, comprising administering the agent of claim 8 to the subject and detecting the presence of the agent in the body or a portion thereof of the subject. |
| Claim: | 12. A method of targeting delivery of a compound to a site of interest within the body of a subject, comprising administering an agent of claim 8 to the subject, wherein the compound is one or more of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 . |
| Current U.S. Class: | 424/91 |
| Patent References Cited: | 5844099 December 1998 Stahl et al. 6472179 October 2002 Stahl et al. 6897294 May 2005 David-Smyth et al. 6916913 July 2005 Jessell et al. 7795389 September 2010 Sun et al. 8318135 November 2012 O'Connor-McCourt et al. 2002/0173621 November 2002 Sledziewski et al. 2003/0125251 July 2003 Wakefield et al. 2004/0176282 September 2004 Dalby et al. 2007/0086942 April 2007 Chang et al. 2007/0154994 July 2007 De Crescenzo et al. 2007/0244042 October 2007 Sun et al. 2010/0120147 May 2010 O'Connor-McCourt et al. 2345109 April 2000 2681177 September 2008 2737271 March 2010 1405915 April 2004 1486560 December 2004 03/020906 March 2003 2008/113185 September 2008 2008/157367 December 2008 2010/031168 March 2010 |
| Other References: | Office Action dated Dec. 8, 2010 on European application 08733651.7. cited by applicant International Preliminary Report on Patentability dated Jun. 5, 2009 on on PCT-CA2008-000547. cited by applicant International Preliminary Report on Patentability dated Mar. 31, 2011 on PCT-CA2009-001293. cited by applicant Written Opinion and International Search Report dated Dec. 10, 2009 on PCT-CA2009-001293. cited by applicant Written Opinion and International Search Report dated Jul. 18, 2008 on PCT-CA2008-000547. cited by applicant Extended European Search Report dated Mar. 22, 2010 on European application 08733651.7. cited by applicant Abe, et al., Analytical Biochemistry, 216, pp. 276-284 (1994). cited by applicant Allendorph et al. PNAS. vol. 103, No. 20, pp. 7643-7648 (2006). cited by applicant Andreeva et al. Nucleic Acids Research. vol. 36, Database issue D419-D425 (2008). cited by applicant Baardsnes et al., Biochemistry, 48, pp. 2146-2155 (2009). cited by applicant Berman et al. Nucleic Acids Research. vol. 28, No. 1, pp. 235-242 (2000). cited by applicant Boesen et al. Structure. vol. 10, pp. 913-919 (2002). cited by applicant Broussau et al., American Society of Gene Therapy, vol. 16, No. 3, pp. 500-507 (2008). cited by applicant Case et al. J Comput Chem. 26, 1668-1688 (2005). cited by applicant Cass et al. Protein Expression and Purification. 40, 77-85 (2005). cited by applicant Cornell et al. J. Am. Chem. Soc. 117, 5179-5197 (1995). cited by applicant Darden et al. J. Chem. Phys. 98(12) 10089-10092 (1993). cited by applicant De Crescenzo et al. The Journal of Biological Chemistry. vol. 279, No. 25, Issue of Jun. 18, pp. 26013-26018 (2004). cited by applicant De Crescenzo et al. The Journal of Biological Chemistry. vol. 276, No. 32, Issue of Aug. 10, pp. 29632-29643 (2001). cited by applicant De Crescenzo et al., J.Mol.Biol., 355, pp. 47-62 (2006). cited by applicant Deep et al. Biochemistry. 42, 10126-10139 (2003). cited by applicant Dennler et al. The EMBO Journal. vol. 17, No. 11, pp. 3091-3100 (1998). cited by applicant Duan et al. J Comput Chem. 24, 1999-2012 (2003). cited by applicant Durocher et al., Nucleic Acids Research, vol. 30, No. 2e9 (2002). cited by applicant Economides et al. Nature Medicine. vol. 9, No. 1, pp. 47-52 (2003). cited by applicant Esparza-Lopez et al. The Journal of Biological Chemistry. vol. 276, No. 18, Issue of May 4, pp. 14588-14596 (2001). cited by applicant Finn et al. Nucleic Acids Research. vol. 34, Database issue D247-D251 (2006). cited by applicant George et al., Protein Engineering, vol. 15, No. 11 pp. 871-879 (2003). cited by applicant Greenwald et al. Molecular Cell. vol. 15, pp. 485-489 (2004). cited by applicant Greenwald et al. Molecular Cell. vol. 11, pp. 605-617 (2003). cited by applicant Groppe et al. Molecular Cell. 29, 157-168 (2008). cited by applicant Hart et al. Nature: Structural Biology. vol. 9, No. 3, pp. 203-208 (2002). cited by applicant Hinck et al. Biochemistry. 35, 8517-8534 (1996). cited by applicant Holash et al. PNAS. vol. 99, No. 17, pp. 11393-11398 (2002). cited by applicant Kingsley, Genes & Development, pp. 133-146 (1994). cited by applicant Kirsch et al. Nature: Structural Biology. vol. 7, No. 6, pp. 492-496 (2000). cited by applicant Larrain et al. Development. 127, 821-830 (2000). cited by applicant Lee et al. Proteins: Structure, Function, and Bioinformatics. 55, 620-634 (2004). cited by applicant Mittl et al. Protein Science. 5:1261-1271 (1996). cited by applicant Naim et al. J. Chem. Inf. Model. 47, 122-133 (2007). cited by applicant Pham et al. Biotechnology and Engineering. vol. 90, No. 3, pp. 332-344 (2005). cited by applicant Ryckaert et al. Journal of Computational Physics. 23, 327-341 (1977). cited by applicant Thompson et al. The EMBO Journal. vol. 22, No. 7, pp. 1555-1566 (2003). cited by applicant Ward et al. J. Mol. Biol. 337, 635-645 (2004). cited by applicant Zilberberg et al. BMC Cell Biology. 8, 41 (2007). cited by applicant |
| Primary Examiner: | Russel, Jeffrey E |
| Attorney, Agent or Firm: | Patenaude, Sonia |
| رقم الانضمام: | edspgr.08658135 |
| قاعدة البيانات: | USPTO Patent Grants |
| الوصف غير متاح. |